Skip to main content

Table 9 Multivariate analysis of serological results incorporating univariate variables with p < 0.2

From: Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland

 

Odds ratio

95% Confidence interval

P value

Hepatitis A IgG negativity

    

 Female gender

0.75

0.50

1.11

0.146

 Increasing age (by year)

0.94

0.93

0.96

 < 0.001

 MSM

0.51

0.22

1.17

0.111

 Heterosexual

0.61

0.26

1.42

0.254

 PWID

0.23

0.09

0.57

0.001

 Ireland

1.10

0.69

1.77

0.682

 Europe

1.84

1.13

3.01

0.015

 Africa

0.12

0.06

0.24

 < 0.001

 South America

1.67

1.00

2.76

0.048

Hepatitis B sAg positivity

    

 Increasing age (by year)

1.02

0.99

1.05

0.190

 MSM

0.43

0.18

1.06

0.066

 Heterosexual

0.83

0.35

1.95

0.664

 Ireland

0.28

0.03

2.26

0.231

 Europe

1.26

0.16

10.02

0.825

 Africa

1.31

0.16

10.57

0.801

 South America

0.33

0.03

3.80

0.373

 Asia and Australasia

1.91

0.21

17.20

0.562

Hepatitis B cAb positivity

    

 Female gender

1.09

0.81

1.48

0.572

 Increasing age (by year)

1.06

1.05

1.08

 < 0.001

 MSM

1.43

0.61

3.35

0.405

 Heterosexual

1.01

0.44

2.31

0.985

 PWID

4.60

1.92

11.01

0.001

 Ireland

0.44

0.33

0.59

 < 0.001

 Africa

2.28

1.56

3.31

 < 0.001

 South America

0.84

0.57

1.23

0.361

Hepatitis B sAb < 10mIU

    

 Female gender

0.91

0.72

1.16

0.454

 MSM

0.55

0.29

1.04

0.068

 Heterosexual

1.23

0.65

2.30

0.525

 PWID

1.05

0.54

2.04

0.878

 Africa

0.81

0.62

1.05

0.109

 South America

0.97

0.72

1.31

0.854

Measles IgG negativity

    

 Female gender

0.84

0.37

1.90

0.675

 Increasing age (by year)

0.91

0.88

0.94

 < 0.001

 MSM

0.53

0.15

1.87

0.323

 Heterosexual

0.42

0.13

1.42

0.165

 PWID

0.65

0.12

3.42

0.612

 Other

1.00

   

 Ireland

0.45

0.14

1.51

0.196

 Europe

2.14

0.67

6.83

0.200

 Africa

0.64

0.17

2.41

0.511

 South America

1.85

0.59

5.78

0.291

 Asia and Australasia

0.23

0.04

1.39

0.108

Mumps IgG negativity

    

 Increasing age (by year)

0.97

0.95

0.99

0.001

 MSM

0.29

0.09

0.91

0.034

 Heterosexual

0.35

0.11

1.06

0.064

 PWID

0.07

0.01

0.45

0.005

 Other

1.00

   

 Ireland

0.93

0.59

1.49

0.770

 Africa

0.42

0.21

0.82

0.012

 South America

1.26

0.79

2.03

0.332

 North America

2.09

0.84

5.20

0.111

Rubella IgG negativity

    

 Female gender

1.63

1.02

2.61

0.042

 Increasing age (by year)

0.96

0.94

0.98

0.001

 PWID

0.53

0.12

2.28

0.391

 Other

2.10

0.69

6.42

0.193

 Ireland

0.80

0.48

1.32

0.376

 Asia and Australasia

2.23

1.05

4.72

0.036

 North America

3.37

1.34

8.47

0.010

VZV IgG negativity

    

 Female gender

1.47

0.86

2.51

0.163

 Increasing age (by year)

0.96

0.94

0.99

0.007

 PWID

3.11

1.32

7.31

0.009

 Ireland

0.56

0.30

1.04

0.067

 Asia and Australasia

1.98

0.81

4.87

0.135

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us